BBOT — BridgeBio Oncology Therapeutics Inc. stock price, charts and financials

QT22BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc. (NASDAQ: BBOT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.87
+0.62+7.52%
OverviewShort InterestFilings
BBOTQT22BridgeBio Oncology Therapeutics Inc.·NASDAQ
8.87+7.52%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 22, 2026424B3Prospectus
Jun 22, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
May 13, 2026424B3Prospectus
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 12, 20264Statement of changes in beneficial ownership
May 12, 20264Statement of changes in beneficial ownership
May 06, 2026424B3Prospectus
May 05, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
May 04, 2026EFFECTNotice of effectiveness
#1 / 25 of 158
Page
▼
/ 7